A new study adds to a growing body of literature suggesting that human insulins may result in similar clinical outcomes as higher cost insulin analogues for many patients with type 2 diabetes, according to a report last week in JAMA. The study looked at an initiative implemented by a Medicare Advantage plan to encourage members with diabetes to switch from insulin analogue to human insulin. The program was associated with a small increase in population-level HbA1C, but no significant change in rates of serious hypoglycemia or hyperglycemia. Human insulin use increased to 70 percent of insulin prescriptions over the three-year initiative, while overall expenditures for insulin decreased by more than 50 percent.

Related News Articles

Headline
Hospitals and health systems are committed to protecting patients from surprise medical bills and support a federal legislative solution to do so, AHA…
Headline
Sens. Bill Cassidy, R-La., Michael Bennet, D-Colo., Todd Young, R-Ind., Maggie Hassan, D-N.H., Lisa Murkowski, R-Alaska, and Tom Carper, D-Del., today…
Headline
The House Ways and Means Committee today held a hearing examining the impact of racial disparities and social determinants of health on maternal mortality.
Headline
A new AHA issue brief describes how hospitals are investing in affordable housing, based on initial findings from the Accelerating Investments for Healthy…
Headline
House Energy and Commerce Committee leaders today released a discussion draft of bipartisan legislation to address surprise medical bills.
Headline
The White House yesterday released a strategy to guide the federal government in protecting the nation from infectious disease threats by working with other…